Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05099328

Recasting or Book Reading by Parents or Clinicians

Recasting and Book Reading Under Ideal (Dose-controlled) and Typical (Dose-variable) Conditions: The Role of Fidelity and Adherence in Production and Comprehension Outcomes for Children With DLD

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
University of Delaware · Academic / Other
Sex
All
Age
4 Years – 9 Years
Healthy volunteers
Not accepted

Summary

Developmental Language Disorder (DLD) affects approximately seven percent of the population and is characterized by grammatical deficits that cascade into lifelong academic challenges and under-employment. Current treatments for DLD produce good outcomes under ideal, high intensity conditions or when parents have been trained to deliver therapy using intense coaching methods; however, current publicly funded service delivery systems and private-pay reimbursement models do not support treatment being delivered in this ideal fashion for children older than three. This project will examine alternative methods of delivering treatment that may be more feasible under typical conditions and will identify implementation barriers, with the goal of improving long-term outcomes for children with DLD. We hypothesize that feasibility and palatability will influence dose, which will in turn affect the overall language outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRecast TherapyRecast therapy is when a interventionist uses the child's own productions as a platform for restating or recasting the child's speech with corrections or alterations to focus on a particular syntax target.
BEHAVIORALSyntax StoriesSyntax stories are specially constructed stories read verbatim designed to teach a syntax target.

Timeline

Start date
2021-09-28
Primary completion
2026-05-30
Completion
2027-08-28
First posted
2021-10-29
Last updated
2025-07-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05099328. Inclusion in this directory is not an endorsement.